Next Article in Journal
Comparison of CD3e Antibody and CD3e-sZAP Immunotoxin Treatment in Mice Identifies sZAP as the Main Driver of Vascular Leakage
Previous Article in Journal
Causative Agents of Ventilator-Associated Pneumonia and Resistance to Antibiotics in COVID-19 Patients: A Systematic Review
 
 
Article
Peer-Review Record

Gut Microbiota and Associated Mucosal Immune Response in Eosinophilic Granulomatosis with Polyangiitis (EGPA)

Biomedicines 2022, 10(6), 1227; https://doi.org/10.3390/biomedicines10061227
by Elena Niccolai 1,†, Alessandra Bettiol 1,†, Simone Baldi 1, Elena Silvestri 1,2, Leandro Di Gloria 3, Federica Bello 1,2, Giulia Nannini 1, Federica Ricci 4, Maria Nicastro 5, Matteo Ramazzotti 3, Augusto Vaglio 3,6, Gianluca Bartolucci 7, Giacomo Emmi 1,2,*,‡, Amedeo Amedei 1,2,*,‡ and Domenico Prisco 1,2,‡
Reviewer 1: Anonymous
Reviewer 2: Anonymous
Biomedicines 2022, 10(6), 1227; https://doi.org/10.3390/biomedicines10061227
Submission received: 8 April 2022 / Revised: 19 May 2022 / Accepted: 19 May 2022 / Published: 24 May 2022
(This article belongs to the Section Immunology and Immunotherapy)

Round 1

Reviewer 1 Report

This study demonstrate that there is not  a substantial intestinal taxonomic dysbiosis in EGPA patients as compared to controls and an enrichment of potential pathobionts sustaining inflammation was observed in EGPA, particularly in patients with active disease. The analysis of the intestinal immune response revealed that a Th1/Th17-mediated response.

These results are new and generally, the manuscript is well written and the data are clearly presented.  

I have the following comment that need to be addressed:

 Concerning the analysis on the mucosal immune response, a comparison with healthy control or other disease is lacking. It will be important to discuss some published data on this aspect.

Author Response

First of all, we want to thank the reviewer for the favorable evaluation of our work and for the effort in revising our manuscript. Regarding its comment, we really thank him for raising this point, giving us the opportunity to improve the quality of our work. Sure, as we discussed, a limit of our study is the impossibility (for ethical reasons) of analyzing the mucosal immune response in enrolled healthy controls. Besides, as suggested by the reviewer, we enhanced our discussion by adding comparisons with other published data (see lines 352-364).

Reviewer 2 Report

I congratulate the authors to write a a very well structured manuscript. Except for some minor improvements, I suggest it to be accepted for publication. 

Specific comments:

Line 219 and elsewhere: Please use italics for applicable genera or family names, if applicable

Line 220-221 and elsewhere: when using the term 'padj' the 'adj' part should be subscript. This would avoid the confusion for the reader

 

Author Response

We really appreciate the positive evaluation of the reviewer and his time dedicated to reviewing our manuscript. According to his suggestions, we applied the italics for genera names and used the subscript format for ‘adj’.

Back to TopTop